In our research, the significantly higher increase rate of NfL in A + PD-MCI, as compared to A-PD-NC was evidence that supports the assertion that dynamic CSF NfL in de novo PD may be consistent with AD pathological process (Olsson et al., 2019). The gene discussed is NEFL; the disease is Parkinson disease.